Historical shareholding details of iShares Micro-Cap ETF holdings in EyePoint Pharmaceuticals Inc (EYPT)

Monthly changes of iShares Micro-Cap ETF shareholding in EyePoint Pharmaceuticals Inc over the previous months

Month Name Total no. shares held Percent Holding
Feb 28, 2025 Ishares Micro-Cap Etf 149,487 0.22%
Feb 27, 2025 Ishares Micro-Cap Etf 147,578 0.21%
Feb 26, 2025 Ishares Micro-Cap Etf 147,578 0.22%
Jan 31, 2025 Ishares Micro-Cap Etf 152,703 0.22%
Jan 29, 2025 Ishares Micro-Cap Etf 152,703 0.22%
Dec 31, 2024 Ishares Micro-Cap Etf 149,526 0.22%
Dec 30, 2024 Ishares Micro-Cap Etf 149,526 0.22%
Nov 30, 2024 Ishares Micro-Cap Etf 114,312 0.17%
Nov 27, 2024 Ishares Micro-Cap Etf 114,312 0.17%
Oct 31, 2024 Ishares Micro-Cap Etf 114,312 0.17%
Oct 30, 2024 Ishares Micro-Cap Etf 114,312 0.17%
Sep 30, 2024 Ishares Micro-Cap Etf 115,100 0.22%
Sep 27, 2024 Ishares Micro-Cap Etf 115,100 0.22%
Sep 25, 2024 Ishares Micro-Cap Etf 115,100 0.22%
Aug 30, 2024 Ishares Micro-Cap Etf 116,517 0.22%
Aug 28, 2024 Ishares Micro-Cap Etf 116,517 0.22%
Jul 31, 2024 Ishares Micro-Cap Etf 114,931 0.22%
Jul 29, 2024 Ishares Micro-Cap Etf 114,931 0.22%
Jun 28, 2024 Ishares Micro-Cap Etf 110,122 0.21%
Jun 13, 2024 Ishares Micro-Cap Etf 77,028 0.15%
May 29, 2024 Ishares Micro-Cap Etf 79,758 0.15%
Apr 26, 2024 Ishares Micro-Cap Etf 80,585 0.15%
Mar 28, 2024 Ishares Micro-Cap Etf 81,570 0.16%
Mar 26, 2024 Ishares Micro-Cap Etf 80,924 0.16%
Feb 29, 2024 Ishares Micro-Cap Etf 59,964 0.12%
Feb 28, 2024 Ishares Micro-Cap Etf 59,964 0.12%
Feb 27, 2024 Ishares Micro-Cap Etf 59,575 0.12%
Jan 29, 2024 Ishares Micro-Cap Etf 59,285 0.12%
Dec 27, 2023 Ishares Micro-Cap Etf 58,895 0.12%
Nov 28, 2023 Ishares Micro-Cap Etf 58,162 0.16%
Oct 31, 2023 Ishares Micro-Cap Etf 57,787 0.16%
Sep 27, 2023 Ishares Micro-Cap Etf 58,354 0.17%
Aug 29, 2023 Ishares Micro-Cap Etf 59,602 0.17%
Jul 28, 2023 Ishares Micro-Cap Etf 59,618 0.17%
Jun 21, 2023 Ishares Micro-Cap Etf 56,847 0.17%
May 30, 2023 Ishares Micro-Cap Etf 56,193 0.16%

View all ownership details of EyePoint Pharmaceuticals Inc